Atb Cap Markets Weighs in on Cresco Labs Q1 Earnings

Cresco Labs Inc. (OTCMKTS:CRLBF - Free Report) - Research analysts at Atb Cap Markets issued their Q1 2025 earnings per share estimates for shares of Cresco Labs in a report issued on Wednesday, March 12th. Atb Cap Markets analyst F. Gomes forecasts that the company will earn ($0.04) per share for the quarter. Atb Cap Markets currently has a "Hold" rating on the stock. The consensus estimate for Cresco Labs' current full-year earnings is ($0.20) per share. Atb Cap Markets also issued estimates for Cresco Labs' FY2025 earnings at ($0.14) EPS and FY2026 earnings at ($0.07) EPS.

Separately, Cormark upgraded Cresco Labs from a "hold" rating to a "moderate buy" rating in a research report on Monday. Two research analysts have rated the stock with a hold rating, one has given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $3.00.

Cresco Labs Stock Up 1.4 %

Shares of CRLBF traded up $0.01 on Monday, hitting $0.72. The company's stock had a trading volume of 2,218,801 shares, compared to its average volume of 621,663. The company has a quick ratio of 1.39, a current ratio of 1.97 and a debt-to-equity ratio of 1.80. The firm's fifty day moving average price is $0.87 and its 200-day moving average price is $1.18. Cresco Labs has a fifty-two week low of $0.70 and a fifty-two week high of $2.60. The firm has a market capitalization of $349.02 million, a price-to-earnings ratio of -3.58 and a beta of 1.79.

Remove Ads

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last issued its quarterly earnings data on Friday, March 14th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. The business had revenue of $176.00 million during the quarter, compared to analyst estimates of $172.10 million.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.